SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

2.

Radioactive ion beams successfully treat animal tumors in study

3.

Early breast cancer detection may be possible with a wearable ultrasound scanner.

4.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

5.

Many patients learn they could have cancer in the emergency department


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot